Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 1/2020

Open Access 01-01-2020 | Gastric Cancer | Original Article – Cancer Research

Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women

Authors: Franziska Clausen, Hans-Michael Behrens, Sandra Krüger, Christoph Röcken

Published in: Journal of Cancer Research and Clinical Oncology | Issue 1/2020

Login to get access

Abstract

Purpose

Tumor-associated neutrophils (TANs) are part of the tumor immune microenvironment (TIME) and may contribute to gastric cancer (GC) biology. We hypothesized that TAN are enriched in the TIME, show sex-specific differences, and correlate with patient outcome.

Methods

We analyzed the distribution and putative tumor biological significance of TANs in a well-characterized, therapy-naïve, European GC cohort using immunohistochemical staining of myeloperoxidase (MPO), and digital image analysis using Definiens Tissue Studio®.

Results

Different tumor compartments were examined, and TAN densities were correlated with various clinicopathological patient characteristics. TAN density showed a large interindividual variability ranging from 0 to 6711.0 TANs/mm2. Intratumoral distribution patterns were inhomogeneous (tumor surface vs. tumor center vs. invasion front) and correlated significantly with Laurén phenotype, tumor grade, and microsatellite status in the tumor center and invasion front. In the multivariate analysis, TAN density in the invasion front was an independent predictor of tumor-specific survival only for women (HR = 2.77, p   < 0.001). In men, no correlation was found between TAN density and survival.

Conclusion

With regard to TANs, our study independently validates sexual dimorphism in GC biology.
Appendix
Available only for authorised users
Literature
go back to reference Abe H et al (2016) In Epstein-Barr virus-associated gastric carcinoma a high density of CD66b-positive tumor-associated neutrophils is associated with intestinal-type histology and low frequency of lymph node metastasis. Virchows Arch 468:539–548CrossRef Abe H et al (2016) In Epstein-Barr virus-associated gastric carcinoma a high density of CD66b-positive tumor-associated neutrophils is associated with intestinal-type histology and low frequency of lymph node metastasis. Virchows Arch 468:539–548CrossRef
go back to reference Altman DG, Mcshane LM, Sauerbrei W, Taube SE (2012) Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med 9:e1001216CrossRef Altman DG, Mcshane LM, Sauerbrei W, Taube SE (2012) Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med 9:e1001216CrossRef
go back to reference Beery AK, Zucker I (2011) Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev 35:565–572CrossRef Beery AK, Zucker I (2011) Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev 35:565–572CrossRef
go back to reference Binnewies M et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24:541–550CrossRef Binnewies M et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24:541–550CrossRef
go back to reference Böger C et al (2016) PD-L1 is an independent prognostic predictor in gastric cancer of Western patients. Oncotarget 7:24269–24283CrossRef Böger C et al (2016) PD-L1 is an independent prognostic predictor in gastric cancer of Western patients. Oncotarget 7:24269–24283CrossRef
go back to reference Böger C, Behrens HM, Krüger S, Röcken C (2017) The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: a future perspective for a combined gastric cancer therapy? Oncoimmunology 6:e1293215CrossRef Böger C, Behrens HM, Krüger S, Röcken C (2017) The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: a future perspective for a combined gastric cancer therapy? Oncoimmunology 6:e1293215CrossRef
go back to reference Brierley JG, Gospodarowicz MK, Wittekind C (2016) TNM classification of malignant tumours, vol 8. Wiley Blackwell, Hoboken Brierley JG, Gospodarowicz MK, Wittekind C (2016) TNM classification of malignant tumours, vol 8. Wiley Blackwell, Hoboken
go back to reference Brusselaers N, Maret-Ouda J, Konings P, El-Serag HB, Lagergren J (2017) Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int J Cancer 140:1693–1699CrossRef Brusselaers N, Maret-Ouda J, Konings P, El-Serag HB, Lagergren J (2017) Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int J Cancer 140:1693–1699CrossRef
go back to reference Cancer Genome Atlas Research N (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202–209CrossRef Cancer Genome Atlas Research N (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202–209CrossRef
go back to reference Caruso RA et al (2002) Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 15:831–837CrossRef Caruso RA et al (2002) Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 15:831–837CrossRef
go back to reference Chatterjee S (2014) Reliability of sexual dimorphism in blood. Indian J Physiol Pharmacol 58:400–402PubMed Chatterjee S (2014) Reliability of sexual dimorphism in blood. Indian J Physiol Pharmacol 58:400–402PubMed
go back to reference Dorak MT, Karpuzoglu E (2012) Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet 3:268CrossRef Dorak MT, Karpuzoglu E (2012) Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet 3:268CrossRef
go back to reference Fridlender ZG et al (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 16:183–194CrossRef Fridlender ZG et al (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 16:183–194CrossRef
go back to reference Fu H et al (2016) Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation. Sci Rep 6:29762CrossRef Fu H et al (2016) Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation. Sci Rep 6:29762CrossRef
go back to reference Group HaCC (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49:347–353CrossRef Group HaCC (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49:347–353CrossRef
go back to reference Huang X et al (2018) Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer. Cancer Med 7:1731–1741CrossRef Huang X et al (2018) Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer. Cancer Med 7:1731–1741CrossRef
go back to reference IWGOTEOCRT Humans (2012) Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100:1–441 IWGOTEOCRT Humans (2012) Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100:1–441
go back to reference Jaillon S, Berthenet K, Garlanda C (2019) Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol 56:308–321CrossRef Jaillon S, Berthenet K, Garlanda C (2019) Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol 56:308–321CrossRef
go back to reference Lauren P (1965) The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31–49CrossRef Lauren P (1965) The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31–49CrossRef
go back to reference Li TJ et al (2017) Interleukin-17-producing neutrophils link inflammatory stimuli to disease progression by promoting angiogenesis in gastric cancer. Clin Cancer Res 23:1575–1585CrossRef Li TJ et al (2017) Interleukin-17-producing neutrophils link inflammatory stimuli to disease progression by promoting angiogenesis in gastric cancer. Clin Cancer Res 23:1575–1585CrossRef
go back to reference Lin SJ et al (2015) Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut 64:1721–1731CrossRef Lin SJ et al (2015) Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut 64:1721–1731CrossRef
go back to reference Markle JG, Fish EN (2014) SeXX matters in immunity. Trends Immunol 35:97–104CrossRef Markle JG, Fish EN (2014) SeXX matters in immunity. Trends Immunol 35:97–104CrossRef
go back to reference Mathiak M et al (2017) Clinicopathologic characteristics of microsatellite instable gastric carcinomas revisited: urgent need for standardization. Appl Immunohistochem Mol Morphol 25:12–24CrossRef Mathiak M et al (2017) Clinicopathologic characteristics of microsatellite instable gastric carcinomas revisited: urgent need for standardization. Appl Immunohistochem Mol Morphol 25:12–24CrossRef
go back to reference Metzger ML et al (2016) MET in gastric cancer discarding a 10% cutoff rule. Histopathology 68(241):253 Metzger ML et al (2016) MET in gastric cancer discarding a 10% cutoff rule. Histopathology 68(241):253
go back to reference Palli D et al (1994) Reproductive history and gastric cancer among post-menopausal women. Int J Cancer 56:812–815CrossRef Palli D et al (1994) Reproductive history and gastric cancer among post-menopausal women. Int J Cancer 56:812–815CrossRef
go back to reference Piccard H, Muschel RJ, Opdenakker G (2012) On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol 82:296–309CrossRef Piccard H, Muschel RJ, Opdenakker G (2012) On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol 82:296–309CrossRef
go back to reference Saeki N, Ono H, Sakamoto H, Yoshida T (2013) Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study. Cancer Sci 104:1–8CrossRef Saeki N, Ono H, Sakamoto H, Yoshida T (2013) Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study. Cancer Sci 104:1–8CrossRef
go back to reference Schoenfeld DA (1983) Sample-size formula for the proportional-hazards regression model. Biometrics 39:499–503CrossRef Schoenfeld DA (1983) Sample-size formula for the proportional-hazards regression model. Biometrics 39:499–503CrossRef
go back to reference Shaul ME, Fridlender ZG (2018) Cancer-related circulating and tumor-associated neutrophils subtypes, sources and function. FEBS J 285:4316–4342CrossRef Shaul ME, Fridlender ZG (2018) Cancer-related circulating and tumor-associated neutrophils subtypes, sources and function. FEBS J 285:4316–4342CrossRef
go back to reference Shen M et al (2014) Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS One 9:e98259CrossRef Shen M et al (2014) Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS One 9:e98259CrossRef
go back to reference Spitzer JA, Zhang P (1996) Gender differences in neutrophil function and cytokine-induced neutrophil chemoattractant generation in endotoxic rats. Inflammation 20:485–498CrossRef Spitzer JA, Zhang P (1996) Gender differences in neutrophil function and cytokine-induced neutrophil chemoattractant generation in endotoxic rats. Inflammation 20:485–498CrossRef
go back to reference Stewart BW, Wild C (2014) World Cancer Report 2014. WHO Press, Geneva Stewart BW, Wild C (2014) World Cancer Report 2014. WHO Press, Geneva
go back to reference Wang TT et al (2017) Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut 66:1900–1911CrossRef Wang TT et al (2017) Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut 66:1900–1911CrossRef
go back to reference Warneke V et al (2013a) Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine. Diagn Mol Pathol 22:127–137CrossRef Warneke V et al (2013a) Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine. Diagn Mol Pathol 22:127–137CrossRef
go back to reference Warneke VS et al (2013b) Her2/neu testing in gastric cancer: evaluating the risk of sampling errors. Ann Oncol 24:725–733CrossRef Warneke VS et al (2013b) Her2/neu testing in gastric cancer: evaluating the risk of sampling errors. Ann Oncol 24:725–733CrossRef
go back to reference Zhang H et al (2018) Tumor-infiltrating neutrophils is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. Ann Surg 267:311–318CrossRef Zhang H et al (2018) Tumor-infiltrating neutrophils is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. Ann Surg 267:311–318CrossRef
go back to reference Zhao JJ et al (2012) The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One 7:e33655CrossRef Zhao JJ et al (2012) The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One 7:e33655CrossRef
Metadata
Title
Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women
Authors
Franziska Clausen
Hans-Michael Behrens
Sandra Krüger
Christoph Röcken
Publication date
01-01-2020
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 1/2020
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-019-03082-z

Other articles of this Issue 1/2020

Journal of Cancer Research and Clinical Oncology 1/2020 Go to the issue